Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.150
+0.003 (2.04%)
At close: Mar 10, 2026
-1.32%
Market Cap 251.70M
Revenue (ttm) 1.09B
Net Income (ttm) 6.76M
Shares Out 1.68B
EPS (ttm) 0.00
PE Ratio 37.22
Forward PE n/a
Dividend 0.01 (3.65%)
Ex-Dividend Date n/a
Volume 530,000
Average Volume 334,000
Open 0.147
Previous Close 0.147
Day's Range 0.147 - 0.150
52-Week Range 0.084 - 0.380
Beta -0.30
RSI 40.93
Earnings Date Mar 27, 2026

About HKG:8329

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology busine... [Read more]

Sector Healthcare
Founded 2002
Employees 1,474
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8329
Full Company Profile

Financial Performance

In 2024, HKG:8329's revenue was 1.04 billion, a decrease of -2.18% compared to the previous year's 1.06 billion. Earnings were 25.01 million, an increase of 3.68%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.